Safety and Efficacy of Combination Therapy with Pegylated Interferon Alpha-2a and Ribavirin in Treating Patients with Chronic Hepatitis C and Beta-Thalassaemia Major: A Greek Single-Center Experience

被引:6
|
作者
Paschos, Paschalis [1 ]
Vlachaki, Efthimia [1 ,2 ]
Pasvanti, Chrisoula [1 ]
Sinakos, Emmanouil [1 ]
Kalpaka, Anastasia [2 ]
Klonizakis, Philippos [1 ]
Perifanis, Vasilios [2 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Med 2, GR-54249 Thessaloniki, Greece
[2] Ippokratio Hosp, Thalassaemia Unit, Thessaloniki, Greece
关键词
MANAGEMENT;
D O I
10.1159/000330516
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:231 / 233
页数:3
相关论文
共 50 条
  • [21] Incidence of retinopathy in chronic Hepatitis C patients treated with pegylated interferon alpha 2a and ribavirin combination therapy
    Kashif, Muhammad
    Saleem, Muhammad Khurram
    Farooka, Imran Khan
    Husnain, Amino
    Siddiqui, Arif Mahmood
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2015, 31 (01) : 174 - 177
  • [22] Efficacy and safety of valopicitabine in combination with pegylated interferon-α (pegIFN) and ribavirin (RBV) in patients with chronic hepatitis C
    Poordad, Fred
    Lawitz, Eric J.
    Gitlin, Norman
    Rodriguez-Torres, Maribel
    Box, Terry
    Nguyen, Tuan
    Pietropaolo, Keith
    Liu, Wei
    Fielman, Barbara A.
    Mayers, Douglas
    [J]. HEPATOLOGY, 2007, 46 (04) : 866A - 866A
  • [23] Pegylated interferon and ribavirin combination therapy for chronic hepatitis C in patients with congenital bleeding disorders: a single-centre experience
    Posthouwer, D.
    Fischer, K.
    De Heusden, N.
    Mauser-Bunschoten, E. P.
    [J]. HAEMOPHILIA, 2007, 13 (01) : 98 - 103
  • [24] EFFICACY OF PEGINTERFERON ALPHA-2A AND RIBAVIRIN COMBINATION THERAPY IN TREATMENT-NAIVE ESTONIAN PATIENTS WITH CHRONIC HEPATITIS C
    Brjalin, Vadim
    Salupere, Riina
    Tallo, Tatjana
    Kuznetsova, Tatiana
    Priimaegi, Ljudmilla
    Tefanova, Valentina
    [J]. CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2012, 20 (02) : 150 - 155
  • [25] Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C
    Hadziyannis, S. J.
    Sevastianos, V.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (04) : 491 - 491
  • [26] Retreatment with pegylated interferon alpha-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapy
    Yoshida, Eric M.
    Sherman, Morris
    Bain, Vincent G.
    Cooper, Curtis L.
    Deschenes, Marc
    Marotta, Paul J.
    Lee, Samuel S.
    Krajden, Mel
    Witt-Sullivan, Helga
    Bailey, Robert J.
    Usaty, Christopher
    Peltekian, Kevork
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 23 (03) : 180 - 184
  • [27] High efficacy of combination therapy with pegylated interferon and ribavirin in hemophiliacs with chronic hepatitis C.
    Mancuso, ME
    Santagostino, E
    Rumi, MG
    Linari, S
    Coppola, A
    Rocino, A
    Iorio, A
    Dragani, A
    Barillari, G
    Tagariello, G
    Nicolin, R
    Colombo, M
    Mannucci, PM
    [J]. BLOOD, 2005, 106 (11) : 899A - 900A
  • [28] Incidence of Depression in Patients with Chronic Hepatitis C Receiving Combination Therapy of Pegylated Interferon-Alpha and Ribavirin
    Mahajan, Sudhir
    Avasthi, Ajit
    Grover, Sandeep
    Chawla, Yogesh K.
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2014, 83 (05) : 308 - 309
  • [29] Pegylated Interferon Alpha-2a in 75 Patients with Myeloproliferative Neoplasms: A Single Center Experience
    Gowin, Krisstina L.
    Jain, Tania
    Kosiorek, Heidi E.
    Camoriano, John
    Tibes, Raoul
    Palmer, Jeanne
    Mesa, Ruben A.
    [J]. BLOOD, 2015, 126 (23)
  • [30] Antiphospholipid syndrome during pegylated interferon alpha-2a therapy for chronic hepatitis C
    Balderramo, D. C.
    Garcia, O.
    Colmenero, J.
    Espinosa, G.
    Forns, X.
    Gines, P.
    [J]. DIGESTIVE AND LIVER DISEASE, 2009, 41 (07) : E4 - E7